These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vitro anti-inflammatory activity of panduratin A isolated from Kaempferia pandurata in RAW264.7 cells.
    Author: Yun JM, Kwon H, Hwang JK.
    Journal: Planta Med; 2003 Dec; 69(12):1102-8. PubMed ID: 14750025.
    Abstract:
    An active compound identified as panduratin A was isolated from a methanol extract of Kaempferia pandurata (Zingiberaceae). We examined the effect of panduratin A on nitric oxide (NO) and prostaglandin E (2) (PGE (2)) production induced by lipopolysaccharide (LPS) in RAW264.7 cells. Modulations of iNOS and COX-2 enzyme expression were evaluated by Western blotting. Panduratin A strongly inhibited both NO (IC (50): 0.175 microM) and PGE (2) (IC (50): 0.0195 microM) production and suppressed both iNOS and COX-2 enzyme expression without any appreciable cytotoxic effect on RAW264.7 cells in a dose-dependent manner. Panduratin A also suppressed the phosphorylation of inhibitor kappaBalpha (IkappaBalpha) and degradation of IkappaBalpha associated with nuclear factor kappaB (NF-kappaB) activation. Furthermore, panduratin A inhibited LPS-induced NF-kappaB transcriptional activity in a dose-dependent manner. These results suggest that panduratin A could exert its inhibitory effects on the production of NO and PGE (2) through the suppression of NF-kappaB activation, indicating its potential for use as an anti-inflammatory agent.
    [Abstract] [Full Text] [Related] [New Search]